BIOMAT Database Logo BIOMAT Database Logo

[Differential use of peripheral vasodilators in the treatment of chronic circulatory failure in patients with mitral valve insufficiency]. 1990

S V Zhilin, and B I Vorob'ev, and A A Kastanaian, and I V Masalitinova

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008944 Mitral Valve Insufficiency Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation. Mitral Incompetence,Mitral Regurgitation,Mitral Valve Incompetence,Mitral Insufficiency,Mitral Valve Regurgitation,Incompetence, Mitral,Incompetence, Mitral Valve,Insufficiency, Mitral,Insufficiency, Mitral Valve,Regurgitation, Mitral,Regurgitation, Mitral Valve,Valve Incompetence, Mitral,Valve Insufficiency, Mitral,Valve Regurgitation, Mitral
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005996 Nitroglycerin A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives. Glyceryl Trinitrate,Anginine,Dynamite,Gilustenon,Nitrangin,Nitro-Bid,Nitro-Dur,Nitrocard,Nitroderm,Nitroderm TTS,Nitroglyn,Nitrol,Nitrolan,Nitrong,Nitrospan,Nitrostat,Perlinganit,Susadrin,Sustac,Sustak,Sustonit,Transderm Nitro,Tridil,Trinitrin,Trinitrolong,Nitro Bid,Nitro Dur,NitroBid,NitroDur,Trinitrate, Glyceryl
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006830 Hydralazine A direct-acting vasodilator that is used as an antihypertensive agent. Hydrallazin,Apresoline,Apressin,Apressoline,Hydralazine Hydrochloride,Hydralazine mono-Hydrochloride,Hydrazinophthalazine,Nepresol,Hydralazine mono Hydrochloride,Hydrochloride, Hydralazine,mono-Hydrochloride, Hydralazine

Related Publications

S V Zhilin, and B I Vorob'ev, and A A Kastanaian, and I V Masalitinova
[Peripheral vasodilators in the treatment of chronic circulatory failure in ischemic heart disease patients].
August 1986, Vrachebnoe delo,
S V Zhilin, and B I Vorob'ev, and A A Kastanaian, and I V Masalitinova
[Heart valve prosthesis in mitral valve defects of patients with chronic circulatory insufficiency].
January 1977, Kardiologiia,
S V Zhilin, and B I Vorob'ev, and A A Kastanaian, and I V Masalitinova
[Effect of peripheral vasodilators on thrombocyte aggregation in chronic circulatory insufficiency].
January 1986, Sovetskaia meditsina,
S V Zhilin, and B I Vorob'ev, and A A Kastanaian, and I V Masalitinova
[Peripheral vasodilators in the treatment of chronic cardiac insufficiency].
May 1987, Klinicheskaia meditsina,
S V Zhilin, and B I Vorob'ev, and A A Kastanaian, and I V Masalitinova
[Peripheral vasodilators and beta-stimulants in the treatment of the initial stages of chronic circulatory insufficiency].
September 1987, Vrachebnoe delo,
S V Zhilin, and B I Vorob'ev, and A A Kastanaian, and I V Masalitinova
[Ambulatory treatment of chronic heart failure with peripheral vasodilators].
November 1984, Kardiologiia,
S V Zhilin, and B I Vorob'ev, and A A Kastanaian, and I V Masalitinova
[Use of vasodilators in post-infarction mitral insufficiency].
January 1984, Sovetskaia meditsina,
S V Zhilin, and B I Vorob'ev, and A A Kastanaian, and I V Masalitinova
[Effects of peripheral vasodilators on arrhythmia in patients with chronic coronary insufficiency].
April 1992, Kardiologiia,
S V Zhilin, and B I Vorob'ev, and A A Kastanaian, and I V Masalitinova
[Circulatory failure in mitral valve stenosis].
July 1971, Polski tygodnik lekarski (Warsaw, Poland : 1960),
S V Zhilin, and B I Vorob'ev, and A A Kastanaian, and I V Masalitinova
[Peripheral vasodilators in the treatment of cardiac insufficiency].
January 1981, Terapevticheskii arkhiv,
Copied contents to your clipboard!